Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA

NCT00784953 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00784953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00784953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
May 31, 2011
Enrollment
842 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma